Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Depressive Episode Associated With Bipolar II Disorder”

8 trials

Showing 8 of 8 results

Early research (Phase 1)Study completedNCT07549581
What this trial is testing

SEP-380135 in Adults With Schizophrenia or Major Depressive Episode

Who this might be right for
SchizophreniaMajor Depressive Disorder (MDD)Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 43
Large-scale testing (Phase 3)UnknownNCT03423680
What this trial is testing

Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression

Who this might be right for
Depression, Bipolar
Korea Otsuka Pharmaceutical Co., Ltd. 390
Large-scale testing (Phase 3)Study completedNCT02600507
What this trial is testing

Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression

Who this might be right for
Bipolar Depression
Intra-Cellular Therapies, Inc. 529
Testing effectiveness (Phase 2)Study completedNCT06429722
What this trial is testing

To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.

Who this might be right for
Major Depressive Episode Associated With Bipolar II Disorder
Neumora Therapeutics, Inc. 18
Large-scale testing (Phase 3)Looking for participantsNCT06372964
What this trial is testing

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Who this might be right for
Bipolar Depression
Intra-Cellular Therapies, Inc. 384
Large-scale testing (Phase 3)Study completedNCT02600494
What this trial is testing

Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression

Who this might be right for
Bipolar Depression
Intra-Cellular Therapies, Inc. 554
Large-scale testing (Phase 3)Study completedNCT03249376
What this trial is testing

Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally

Who this might be right for
Bipolar Depression
Intra-Cellular Therapies, Inc. 381
Large-scale testing (Phase 3)Study completedNCT04285515
What this trial is testing

Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder

Who this might be right for
Bipolar DepressionMajor Depressive Disorder
Intra-Cellular Therapies, Inc. 488

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation